UHAS Researchers Warn of Rising Candida Resistance as 70% of Cases Resist Common Antifungals

Ghanaian health experts are warning of a significant public health threat as Candida albicans, the primary cause of yeast infections, shows alarming levels of resistance to standard treatments. Recent research from the University of Health and Allied Sciences (UHAS) in Ho reveals that approximately 70 percent of Candida isolates in the country are now resistant to fluconazole, one of the most commonly prescribed antifungal medications. This shift represents a critical challenge for the nation's healthcare system, as infections that were once easily managed are becoming increasingly difficult to treat. The study, conducted by researchers in the department of Biochemistry and Molecular Biology, highlights a disparity in how antimicrobial resistance is addressed. While bacterial resistance to antibiotics has long been a focus of national health policy, fungal infections—and specifically the emergence of antifungal resistance—have historically received significantly less attention. This neglect has created a gap in clinical knowledge and patient care, as medical practitioners often prescribe treatments without the necessary diagnostic data to confirm efficacy. Compounding the issue is the limited infrastructure for fungal diagnostics across Ghana’s healthcare facilities. Many laboratories lack the specialized equipment and trained personnel required for comprehensive medical mycology. Without routine antifungal susceptibility testing, clinicians are frequently forced to rely on empirical treatment, which can inadvertently accelerate the development of drug-resistant strains. Experts point out that the lack of widespread awareness regarding the nuances of fungal pathogens further hinders the effective management of these infections in both primary and tertiary care settings. To combat this emerging threat, researchers and public health advocates are calling for an immediate scale-up of laboratory capacity and the integration of routine antifungal testing into standard clinical protocols. Strengthening national surveillance systems to monitor resistance patterns is essential for informing treatment guidelines and preserving the effectiveness of remaining antifungal drugs. As Ghana navigates this silent crisis, the UHAS findings serve as a clarion call for the health ministry and relevant stakeholders to prioritize medical mycology as a vital component of the broader fight against antimicrobial resistance.